Long-term growth injections for short children
Part of Bones, joints & muscles, Brain & nervous system, Genetic & congenital, Heart & circulation, Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial studies the long-term safety and effectiveness of Growtropin®-II, a growth hormone–type injection, in children who are short due to certain causes. It may help your child’s growth over time, while also closely tracking side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is short and has one of these reasons: growth hormone deficiency, no known cause, Turner syndrome, or born small for gestational age
- You have a documented height record for your child from at least 6 months ago
- Your child’s growth plates at the ends of the bones are still open (not closed)
- Your child is able to stay in the study for long-term follow-up visits
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows children who are short for their age and checks how safe and effective growth hormone is over the long term. It may help families understand expected benefits and side effects for their specific growth-related condition.
This trial tests a weekly growth hormone injection (lonapegsomatropin) compared to the standard daily growth hormone shot in children with short stature due to certain conditions. It aims to see if the weekly shot works as well or better and is safe.
This study tests an experimental growth hormone (Inpegsomatropin) to help children born small for gestational age who remain short. If your child meets the specific height, age, and puberty criteria, they may qualify.
This study tests a new growth hormone injection (Inpegsomatropin) to help children with idiopathic short stature (short stature with no known cause) grow taller. It may be an option if your child is very short compared to peers and has not started puberty.
This study tests whether a new long-acting growth hormone injection helps girls with Turner syndrome grow taller. Turner syndrome is a genetic condition that affects growth, and this trial will see if this treatment is safe and effective.
This trial tests an investigational drug called GenSci134 for children with idiopathic short stature (short height with no known cause). It aims to see if the drug can help them grow taller. The study is for children who have not been treated with growth hormones before.
Hear when a new Growth Hormone Deficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.